ClinConnect ClinConnect Logo
Search / Trial NCT05857462

The Impact of Integrated Preoperative Fascia Iliaca Compartment Block in Elderly Hip Fracture

Launched by MAHIDOL UNIVERSITY · May 4, 2023

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a specific type of pain relief called the fascia iliaca compartment block (FICB) to see if it helps older adults with hip fractures during their hospital stay and after surgery. The main goal is to find out if using this pain relief technique can reduce the chances of patients developing delirium, which is a sudden change in mental status often seen in older individuals during hospitalization. Additionally, the study will look at how much pain patients feel before and after surgery, any complications that might arise, and the overall length of their hospital stay.

To participate in this trial, patients need to be between 65 and 85 years old and have a hip fracture that requires surgery. They should be experiencing moderate pain when they arrive at the hospital. However, those with certain medical conditions or who cannot communicate properly will not be included. If eligible, participants can expect to receive either the pain relief treatment or standard care and will be monitored closely for any changes in their condition during their hospital stay. This study is being conducted across multiple hospitals and aims to improve pain management and outcomes for older adults facing hip fracture surgery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Patients who are aged ≥65 , \<85 years old and diagnose hip fracture in 8 hospitals
  • 2. Planed for fast-track hip surgery
  • 3. Isolated acute hip fracture
  • 4. Pain on admission during movement ≥ 4 (moderate pain)
  • Exclusion Criteria:
  • 1. refusal to participate the study
  • 2. ASA physical status \>III
  • 2. duration of fracture more than 7 days before admission 3. hip fracture after/at previous instrumentation 4. hip fracture causing by a traffic accident or high energy force 5. suspected pathologic fracture 6. unable to communication 7. abnormal consciousness or severe cognitive dysfunction that could not communication such as mental retardation, severe Alzheimer's disease and schizophenia 8. allergy to local anesthetic drug

About Mahidol University

Mahidol University, a premier institution in Thailand, is dedicated to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the university leverages its extensive expertise in medical and health sciences to facilitate rigorous scientific investigations aimed at improving patient care and public health outcomes. With a commitment to ethical practices and collaboration, Mahidol University fosters multidisciplinary approaches, engaging a diverse array of researchers and healthcare professionals to drive meaningful advancements in clinical research.

Locations

Bangkok Noi, Bangkok, Thailand

Patients applied

0 patients applied

Trial Officials

Suwimon Tangwiwat, MD

Principal Investigator

Mahidol University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported